Is Teduglutide legal in Australia?

Teduglutide in Australia at a glance

Classification and note come from the Teduglutide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

• 01

  TGA has approved Teduglutide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

• 02

  Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

• 03

  Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Teduglutide is

An FDA-approved GLP-2 analogue that promotes intestinal growth in short bowel syndrome, reducing dependence on IV nutrition.

Teduglutide is a GLP-2 receptor agonist approved as Gattex for short bowel syndrome. Unlike the GLP-1 drugs used for diabetes and obesity, GLP-2 acts on the intestinal lining, increasing absorptive surface area.

Mechanism: Activates GLP-2 receptors in the gut to stimulate growth of the intestinal mucosa and improve nutrient absorption.

Regulatory history: FDA-approved (Gattex) for short bowel syndrome

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Teduglutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Teduglutide in other countries

Frequently asked questions

Related compounds in Australia